fig3
From: A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
Figure 3. Bispecific T cell engager binding CD3 on T cell with PSMA on prostate cancer cell. BiTE: Bispecific T-cell engager; PSMA: prostate-specific membrane antigen.
